Allergy Therapeutics plc (LON:AGY – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as GBX 8 ($0.10) and last traded at GBX 7.70 ($0.09), with a volume of 230809 shares traded. The stock had previously closed at GBX 7.70 ($0.09).
Allergy Therapeutics Price Performance
The company’s 50-day simple moving average is GBX 6.24 and its 200 day simple moving average is GBX 5.29. The stock has a market capitalization of £367.29 million, a price-to-earnings ratio of -128.33, a P/E/G ratio of -30.70 and a beta of 1.40. The company has a quick ratio of 1.48, a current ratio of 1.40 and a debt-to-equity ratio of 37.22.
Allergy Therapeutics Company Profile
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Read More
- Five stocks we like better than Allergy Therapeutics
- What is MarketRank™? How to Use it
- SAP’s Strong Momentum: A Bullish Setup for Investors
- 3 Dividend Kings To Consider
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Roth IRA Calculator: Calculate Your Potential Returns
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
